FindTrial
Sign In

The clearance effect of combination of hemodialysis with hemoperfusion on Protein-Bound Uremic Toxins in maintenance hemodialysis patients

The clearance effect of combination of hemodialysis with hemoperfusion on Protein-Bound Uremic Toxins in maintenance hemodialysis patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038640
Enrollment
Unknown
Registered
2020-09-26
Start date
2020-09-21
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal disease

Interventions

HD+HP:HP once a week

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. The dialysis mode of stable maintenance hemodialysis patients with dialysis age >=3 months was relatively fixed; 3. Blood purification time >=10 hours per week; 4. Kt / V >=1.2 in the first 8 weeks; 5. Sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. Life expectancy < 1 year; 2. White blood cell count < 4x10^9/L or platelet count < 100x10^9/L; 3. Active or chronic gastrointestinal bleeding, or with clear coagulation dysfunction; 4. Malignant tumor; 5. Active infection; 6. Pregnancy or lactation; 7. The patients were treated with regular hemoperfusion for more than 6 months and at least once every 2 weeks; 8. Those who are unable or unwilling to comply with the requirements of the protocol formulated by the researcher.

Design outcomes

Primary

MeasureTime frame
PCS;IS;—

Countries

China

Contacts

Public ContactJiangtao Li

Tongji Hospital of Tongji University

lijiangtaosuyan@126.com+86 13918366265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026